The somewhat surprising finding came from a study of the lifespan and diets of more than 5,200 adults aged 80 and over.
The CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback